Myeloproliferative Disorders Treatment Market Poised to Capitalize on Rising Demand and Innovation
Market Overview The global myeloproliferative disorder treatment market was valued at USD 9.20 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.6% during the forecast period. Myeloproliferative disorders (MPDs) are a group of hematologic diseases characterized by the excessive production of blood cells in the bone marrow. These disorders can lead...
0 Commenti 0 Condivisioni 90 Visualizzazioni